Showing results (61-70 of 831) with videos related to
Sort By:
Pageof 84
Blood Reviews|December 4, 2010
Multiple myeloma: biology of the diseaseAnuj Mahindra, Teru Hideshima, Kenneth C AndersonInternational Journal of Hematology|April 22, 2016
Histone deacetylase inhibitors in multiple myeloma: from bench to bedsideTakeshi Harada, Teru Hideshima, Kenneth C AndersonBlood Cancer Journal|September 8, 2018
The biological significance of histone modifiers in multiple myeloma: clinical applicationsHiroto Ohguchi, Teru Hideshima, Kenneth C AndersonReviews in Clinical and Experimental Hematology|March 6, 2003
Novel biologically based therapeutic strategies in myelomaDeepak Gupta, Teru Hideshima, Kenneth C AndersonExpert Review of Anticancer Therapy|October 6, 2006
Therapeutic use of immunomodulatory drugs in the treatment of multiple myelomaNoopur Raje, Teru Hideshima, Kenneth C AndersonExperimental Hematology|June 30, 2015
Novel therapeutic strategies for multiple myelomaNaoya Mimura, Teru Hideshima, Kenneth C AndersonImmunological Reviews|July 9, 2003
Novel therapeutic approaches for multiple myelomaTeru Hideshima, Paul Richardson, Kenneth C AndersonHematology/Oncology Clinics of North America|November 13, 2007
The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapiesConstantine S Mitsiades, Douglas W McMillin, Steffen Klippel, et al.Molecular Cancer Therapeutics|December 21, 2002
Arsenic trioxide inhibits growth of human multiple myeloma cells in the bone marrow microenvironmentToshiaki Hayashi, Teru Hideshima, Masaharu Akiyama, et al.British Journal of Haematology|July 19, 2006
Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomibReshma Shringarpure, Laurence Catley, Deepak Bhole, et al.Pageof 84